Yu‐Ju Wei

490 total citations
28 papers, 139 citations indexed

About

Yu‐Ju Wei is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Yu‐Ju Wei has authored 28 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Hepatology and 3 papers in Molecular Biology. Recurrent topics in Yu‐Ju Wei's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (14 papers). Yu‐Ju Wei is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (14 papers). Yu‐Ju Wei collaborates with scholars based in Taiwan, Switzerland and China. Yu‐Ju Wei's co-authors include Chia‐Yen Dai, Ming‐Lung Yu, Chung‐Feng Huang, Po‐Cheng Liang, Ming‐Lun Yeh, Wan‐Long Chuang, Ming‐Yen Hsieh, Jee‐Fu Huang, Yi‐Hung Lin and Tyng‐Yuan Jang and has published in prestigious journals such as PLoS ONE, World Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Yu‐Ju Wei

23 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ju Wei Taiwan 8 79 65 26 18 9 28 139
Álvaro Giráldez Gallego Spain 7 67 0.8× 47 0.7× 20 0.8× 20 1.1× 8 0.9× 33 154
Ghideon Ezaz United States 8 94 1.2× 85 1.3× 19 0.7× 21 1.2× 4 0.4× 13 172
Carole Cagnot France 8 109 1.4× 120 1.8× 18 0.7× 20 1.1× 6 0.7× 19 192
Tania N. Kamphaus United States 4 73 0.9× 34 0.5× 15 0.6× 7 0.4× 26 2.9× 7 123
Valentina Liakina Lithuania 8 98 1.2× 83 1.3× 22 0.8× 4 0.2× 7 0.8× 27 159
Manon Allaire France 7 65 0.8× 93 1.4× 15 0.6× 20 1.1× 4 0.4× 14 132
Antoine Boustany United States 7 64 0.8× 28 0.4× 11 0.4× 4 0.2× 18 2.0× 29 112
Marko Korenjak Spain 5 62 0.8× 54 0.8× 7 0.3× 7 0.4× 9 1.0× 7 92
David Toapanta Spain 6 66 0.8× 65 1.0× 36 1.4× 4 0.2× 4 0.4× 17 134
Cristina Alonso Spain 7 91 1.2× 71 1.1× 55 2.1× 5 0.3× 4 0.4× 18 161

Countries citing papers authored by Yu‐Ju Wei

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ju Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ju Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ju Wei more than expected).

Fields of papers citing papers by Yu‐Ju Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ju Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ju Wei. The network helps show where Yu‐Ju Wei may publish in the future.

Co-authorship network of co-authors of Yu‐Ju Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ju Wei. A scholar is included among the top collaborators of Yu‐Ju Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ju Wei. Yu‐Ju Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Tyng‐Yuan, Yuting Zeng, Po‐Cheng Liang, et al.. (2025). Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Alimentary Pharmacology & Therapeutics. 61(9). 1458–1466.
2.
Lin, Tzu‐Chun, Pei‐Chien Tsai, Chung‐Feng Huang, et al.. (2025). A Point‐of‐Care Model for Hepatitis C Elimination in Remote Islands of Taiwan. The Kaohsiung Journal of Medical Sciences. 41(10). e70060–e70060.
3.
Huang, Chung‐Feng, Ming‐Lun Yeh, Yu‐Ju Wei, et al.. (2025). Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication. Alimentary Pharmacology & Therapeutics. 63(8). 1119–1131. 1 indexed citations
4.
Jang, Tyng‐Yuan, Chih‐Wen Wang, Po‐Cheng Liang, et al.. (2025). Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 40(9). 2290–2299.
5.
Wei, Yu‐Ju, Pei‐Chien Tsai, Ming‐Lun Yeh, et al.. (2025). Hepatitis C virus‐free endoscope procedures project: An in‐hospital elimination approach. The Kaohsiung Journal of Medical Sciences. 41(3). e12942–e12942.
6.
Wei, Yu‐Ju, Chih‐Wen Wang, Po‐Cheng Liang, et al.. (2025). Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes. World Journal of Gastroenterology. 31(10). 103716–103716. 1 indexed citations
7.
Huang, Chung‐Feng, Chih‐Wen Wang, Tyng‐Yuan Jang, et al.. (2024). Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
8.
Huang, Chung‐Feng, Po‐Cheng Liang, Chih‐Wen Wang, et al.. (2024). Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis. The Kaohsiung Journal of Medical Sciences. 40(4). 374–383. 3 indexed citations
9.
Yeh, Ming‐Lun, Chia‐Yen Dai, Chung‐Feng Huang, et al.. (2024). The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients. The Kaohsiung Journal of Medical Sciences. 40(6). 575–582. 1 indexed citations
10.
Jang, Tyng‐Yuan, Yong Zeng, Po‐Cheng Liang, et al.. (2024). Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues. Liver International. 45(4). e16149–e16149. 4 indexed citations
11.
Huang, Chung‐Feng, Chia‐Yen Dai, Yi‐Hung Lin, et al.. (2024). Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan. Clinical and Molecular Hepatology. 30(4). 883–894. 2 indexed citations
12.
Jang, Tyng‐Yuan, Po‐Cheng Liang, Yu‐Ju Wei, et al.. (2023). Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease. The Kaohsiung Journal of Medical Sciences. 40(3). 304–314. 10 indexed citations
13.
Lee, Kuan‐I, Po‐Cheng Liang, Po‐Yao Hsu, et al.. (2023). Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences. 39(11). 1145–1154. 2 indexed citations
14.
Huang, Chung‐Feng, Po‐Cheng Liang, Pei‐Chien Tsai, et al.. (2023). The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area. Journal of Gastroenterology and Hepatology. 39(1). 193–201. 4 indexed citations
15.
Jang, Tyng‐Yuan, Yi‐Hung Lin, Po‐Cheng Liang, et al.. (2022). Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. The Kaohsiung Journal of Medical Sciences. 38(9). 897–906. 4 indexed citations
16.
Yeh, Ming‐Lun, Po‐Cheng Liang, Ching‐I Huang, et al.. (2021). Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community‐based cohort study. Journal of Gastroenterology and Hepatology. 36(11). 3239–3246. 1 indexed citations
17.
Liang, Po‐Cheng, Ching‐I Huang, Ming‐Lun Yeh, et al.. (2021). Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals. PLoS ONE. 16(2). e0245479–e0245479. 7 indexed citations
18.
Wei, Yu‐Ju, et al.. (2020). The influence of integrated geriatric outpatient clinics on the health care utilization of older people. BMC Geriatrics. 20(1). 379–379. 14 indexed citations
19.
Huang, Chung‐Feng, Ming‐Lun Yeh, Ching‐I Huang, et al.. (2019). Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study. BMJ Open. 9(5). e026703–e026703. 11 indexed citations
20.
Li, Xiandong, et al.. (2015). Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma. World Journal of Surgical Oncology. 13(1). 5–5. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026